12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Company News  |  Other News

Affitech cancer news

Affitech shareholder Trans Nova Investments Ltd. made a new offer to acquire the 28.7% of Affitech it does not already own for DKK0.20 per share in cash. Earlier this month, Affitech said NASDAQ OMX Copenhagen would accept the company's request to delist contingent on a new offer...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >